Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



@@#116300@@

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 9 novembre 2019
Doi : 10.1016/j.jaad.2019.08.022
Use of new molecular tests for melanoma by pigmented-lesion experts
 

Amir Varedi, MD a, Laura J. Gardner, MD b, Caroline C. Kim, MD c, Emily Y. Chu, MD, PhD d, Michael E. Ming, MD, MSCE d, Sancy A. Leachman, MD, PhD e, Clara Curiel-Lewandrowski, MD f, Susan M. Swetter, MD g, Douglas Grossman, MD, PhD a, h, i,
a Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City 
b University of Utah School of Medicine, Salt Lake City 
c Department of Dermatology, Beth Israel Deaconess Medical Center, Boston 
d Department of Dermatology, University of Pennsylvania, Philadelphia 
e Department of Dermatology, Oregon Health Sciences University, Portland 
f Department of Medicine, The University of Arizona Cancer Center, Tucson 
g Department of Dermatology, Stanford University Medical Center and Veterans Affairs Palo Alto Health Care System, Palo Alto, California 
h Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City 
i Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City 

Reprint requests to: Douglas Grossman, MD, PhD, Huntsman Cancer Institute, 2000 Circle of Hope, Salt Lake City, UT 84112Huntsman Cancer Institute2000 Circle of HopeSalt Lake CityUT84112

 Drs Varedi and Gardner contributed equally to this article.
 Funding sources: Dr Grossman is supported by the University of Utah Department of Dermatology and the Huntsman Cancer Foundation.
 Disclosure: Dr Leachman received honoraria for serving on the advisory boards of Orlucent and Merck. Dr Grossman received honoraria for serving on the advisory board of Orlucent. Drs Varedi, Gardner, Kim, Chu, Ming, Curiel-Lewandrowski, and Swetter have no conflicts of interest to declare.


Top of the page

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@